Literature DB >> 21794898

Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: an updated meta-analysis.

Yan Ping Liu, Pan Pan Hao, Ming Xiang Zhang, Cheng Zhang, Fei Gao, Yun Zhang, Yu Guo Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21794898     DOI： 10.1016/j.thromres.2011.07.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis.

Authors:  Xuan Niu; Ling Mao; Yan Huang; Suraj Baral; Jian-Yong Li; Yuan Gao; Yuan-Peng Xia; Quan-Wei He; Meng-Die Wang; Man Li; Li Zou; Xiao-Ping Miao; Bo Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.

Authors:  Gilberto Vargas-Alarcón; Julián Ramírez-Bello; Aurora de la Peña; Beatriz Calderón-Cruz; Marco Antonio Peña-Duque; Marco Antonio Martínez-Ríos; Silvestre Ramírez-Fuentes; Oscar Pérez-Méndez; José Manuel Fragoso
Journal:  Mol Biol Rep       Date:  2014-08-09       Impact factor: 2.316

Review 3.  Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention.

Authors:  Larisa H Cavallari
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-19

Review 4.  Pharmacogenetics and cardiovascular disease--implications for personalized medicine.

Authors:  Julie A Johnson; Larisa H Cavallari
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

5.  CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Authors:  Caitrin W McDonough; Leslie A McClure; Braxton D Mitchell; Yan Gong; Richard B Horenstein; Joshua P Lewis; Thalia S Field; Robert L Talbert; Oscar R Benavente; Julie A Johnson; Alan R Shuldiner
Journal:  J Am Heart Assoc       Date:  2015-05-27       Impact factor: 5.501

Review 6.  A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users.

Authors:  Ruben L Osnabrugge; Stuart J Head; Felix Zijlstra; Jurriën M ten Berg; Myriam G Hunink; A Pieter Kappetein; A Cecile J W Janssens
Journal:  Genet Med       Date:  2014-06-19       Impact factor: 8.822
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.